Francis Lo sold $1.8M of Adaptive Biotechnologies (ADPT)

Executed Dec 15 2025, disclosed Dec 17 2025, 2 days later.

Value, as filed

$1.8M

113,890 sh × $15.57

Executed

Dec 15 2025

the trade date, as filed

Disclosed

Dec 17 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Francis Lo Chief People Officer profile →

Francis Lo (Chief People Officer) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $3.2M of ADPT (115,406 sh across 2 lots, as filed), executed Sep 16.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 69 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Francis Lo in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $3.2M
115,406 sh across 2 lots
Exec Sep 16
Filed Sep 18 · 8:17 PM ET ADPTSALE Adaptive Biotechnologies Corporation $2.4M
105,762 sh × $22.59
Exec Jul 15
Filed Jul 17 · 7:23 PM ET ADPTSALE Adaptive Biotechnologies Corporation $2.2M
95,842 sh across 3 lots
Exec Jul 1
Filed Jul 6 · 7:19 PM ET ADPTSALE Adaptive Biotechnologies Corporation $695K
39,741 sh × $17.49
Exec Jun 4
Filed Jun 8 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $340K
22,564 sh × $15.07
Exec Apr 8
Filed Apr 10 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $431K
30,593 sh × $14.08
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $575K
38,074 sh × $15.09
Exec Mar 5
Filed Mar 9 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.4M
79,590 sh × $17.73
Exec Jan 12
Filed Jan 14 · 5:30 PM ET